Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001104659-18-022600

Options or other derivatives

  • Chief Executive Officer acquired 187,628 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
TABUTEAU HERRIOT Chief Executive Officer 2018-03-12 Grant or award · Employee Stock Option (Right to Buy) +187,628 187,628 D
Loading xslF345X03/a4.xml…